NMN–Polyphenol–L-Ergothioneine Blend

Define your ingredient input

Define beta-NMN, trans-resveratrol, the quercetin–sunflower lecithin complex, apigenin, luteolin and L-ergothioneine as separate inputs within the proposed composition. Request a complete declaration for the quercetin complex as well as the other preparations. Their proportions, physical delivery form and project requirements must be discussed without assuming a proprietary formula or a particular regulatory suitability.

Discuss your procurement requirements

• Does the project require the named combination of Beta-Nicotinamide Mononucleotide, Trans-Resveratrol, Quercetin–Sunflower Lecithin Complex, Apigenin, Luteolin, L-Ergothioneine?
• How should beta-NMN, trans-resveratrol and the remaining named inputs be identified individually?
• What composition declaration is required for the quercetin–sunflower lecithin component without assuming a trademark-equivalent preparation?
• What relative composition should be agreed without copying the finished-product serving amounts?
• What actual physical delivery form, preparations and any carrier components should suppliers declare?
• Which constituent identity, content or other requested analytical methods should be reviewed?
• What quantity in kg, packaging brief and destination should the supplier assess?
• Which composition, handling and traceability documents are requested for comparison?
• Are samples or additional tests requested, subject to supplier confirmation of scope and availability?

Confirm the offered specification, analytical methods, sample arrangements and documentation with the proposed supplier for your intended project.

Formulation and procurement gallery